meta_analysis
    2018

    Efficacy and safety of a hexanic extract of Serenoa repens (Permixon) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: systematic review and meta-analysis

    Vela-Navarrete R, Alcaraz A, Rodriguez-Antolin A, Minana Lopez B, Fernandez-Gomez JM, Angulo JC, Castro Diaz D, Romero-Otero J, Brenes FJ, Carballido J, Molero Garcia JM, Fernandez-Pro Ledesma A, Cozar Olmos JM, Manasanch Dalmau J, Subirana Cachinero I, Herdman M, Ficarra V

    Published in BJU International

    Key Findings

    The hexanic Serenoa repens extract reduced nocturia and improved peak urinary flow versus placebo, with effects on IPSS comparable to tamsulosin.

    Conclusions

    Extract-specific preparations may perform better than generic saw palmetto products.

    Limitations

    Restricted to one branded extract; several trials manufacturer sponsored.

    Supplements Studied

    The hexanic Serenoa repens extract reduced nocturia and improved peak urinary flow versus placebo.

    Outcomes Measured

    The hexanic Serenoa repens extract reduced nocturia and improved peak urinary flow versus placebo.

    Study Details

    Year:2018
    00
    Quality Score:6/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.